SEC Form 4 · accession 0001209191-17-036280
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger C Lucas
Director
Period of report
May 25, 2017
Accepted (ET)
May 30, 2017 · 7:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 25, 2017 | A | 12,912 | $0.00 | A | 75,734 | D | |
| Common Stock | May 26, 2017 | M | 20,362 | $0.00 | A | 96,096 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3,F4 | — | May 26, 2017 | M | 20,362 | D | — | — | Common Stock | 20,362 | 0 | D |
Explanation of responses
- F1The restricted stock was awarded on May 25, 2017, and 100% of the restricted stock will vest on May 25, 2018, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.
- F2Shares were acquired upon vesting of restricted stock units awarded on May 26, 2016.
- F3Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
- F4100% of the restricted stock units vested on May 26, 2017. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.